Tamsulosin Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00706 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 46 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 2 | hypertrichosis (disease) | KG + DL |
| 3 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 4 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 5 | isolated genetic hair shaft abnormality | KG + DL |
| 6 | hypotrichosis simplex of the scalp | KG + DL |
| 7 | congenital hypotrichosis milia | KG + DL |
| 8 | diffuse alopecia areata | KG + DL |
| 9 | alopecia | KG + DL |
| 10 | migraine with brainstem aura | KG + DL |
| 11 | migraine disorder | KG + DL |
| 12 | familial isolated trichomegaly | KG + DL |
| 13 | persistent fetal circulation syndrome | KG + DL |
| 14 | 16q24.1 microdeletion syndrome | KG + DL |
| 15 | isolated pulmonary capillaritis | KG + DL |
| 16 | primary interstitial lung disease specific to childhood | KG + DL |
| 17 | congenital pulmonary lymphangiectasia | KG + DL |
| 18 | allergic urticaria | KG + DL |
| 19 | prostate calculus | KG + DL |
| 20 | respiratory failure | KG + DL |
| 21 | congenital alveolar capillary dysplasia | KG + DL |
| 22 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 23 | pulmonary arterial hypertension associated with congenital heart disease | KG + DL |
| 24 | pulmonary arterial hypertension | KG + DL |
| 25 | trigeminal autonomic cephalalgia | KG + DL |
| 26 | genetic alopecia | KG + DL |
| 27 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 28 | kyphoscoliotic heart disease | KG + DL |
| 29 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 30 | headache disorder | KG + DL |
| 31 | pulmonary arteriovenous malformation (disease) | KG + DL |
| 32 | pulmonary hypertension | KG + DL |
| 33 | pulmonary arterial hypertension associated with chronic hemolytic anemia | KG + DL |
| 34 | pulmonary arterial hypertension associated with connective tissue disease | KG + DL |
| 35 | pulmonary arterial hypertension associated with HIV infection | KG + DL |
| 36 | pulmonary arterial hypertension associated with schistosomiasis | KG + DL |
| 37 | pseudopelade of Brocq | KG + DL |
| 38 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 39 | coxopodopatellar syndrome | KG + DL |
| 40 | chronic thromboembolic pulmonary hypertension | KG + DL |
| 41 | atrophoderma vermiculata | KG + DL |
| 42 | Raynaud disease | KG + DL |
| 43 | nasopharyngitis | KG + DL |
| 44 | ulerythema ophryogenesis | KG + DL |
| 45 | primary hereditary glaucoma | KG + DL |
| 46 | syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.